BiotechTube

Eltrombopag

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Thrombocytopenia Purpura

Conditions

Thrombocytopenia Purpura, Chronic HBV Infection

Trial Timeline

Dec 4, 2018 → Sep 30, 2022

NCT ID
NCT03664518

About Eltrombopag

Eltrombopag is a phase 2 stage product being developed by Novartis for Thrombocytopenia Purpura. The current trial status is completed. This product is registered under clinical trial identifier NCT03664518. Target conditions include Thrombocytopenia Purpura, Chronic HBV Infection.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (11)

NCT IDPhaseStatus
NCT04837703Pre-clinicalActive
NCT05286164Phase 2UNKNOWN
NCT03988608Phase 2Completed
NCT03718533Phase 2Terminated
NCT03664518Phase 2Completed
NCT03524612Phase 2Completed
NCT02877212Phase 3UNKNOWN
NCT02323178Phase 1/2Completed
NCT01703169Phase 2Completed
NCT01715779Pre-clinicalCompleted
NCT01416311Pre-clinicalCompleted

Competing Products

20 competing products in Thrombocytopenia Purpura

See all competitors
ProductCompanyStageHype Score
Pirtobrutinib + PlaceboEli LillyPhase 1/2
41
Anti-(integrin beta-3) human monoclonal antibodyRallybioPhase 2
44
Placebo + LusutrombopagShionogiPhase 2
52
LusutrombopagShionogiPhase 2
52
Avatrombopag + Avatrombopag + PlaceboEisaiPhase 2
52
avatrombopagEisaiPhase 1
33
E5501 + Drug: E5501EisaiPhase 1
33
avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
77
avatrombopag + PlaceboEisaiPhase 2
52
Avatrombopag + Placebo + Pegylated interferon (PEG-IFN) + Telaprevir + RibavirinEisaiPhase 2
52
avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
77
Avatrombopag + Placebo + Standard of careEisaiPhase 3
77
RomiplostimKyowa KirinPhase 1/2
41
Romiplostim + PlaceboKyowa KirinPhase 3
77
Romiplostim (AMG-531)Kyowa KirinPhase 2
52
Romiplostim and danazolKyowa KirinPhase 2
52
ONO-7746Ono PharmaceuticalPhase 1
33
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 1
33
Hetrombopag Olamine + Hetrombopag Olamine ；Hetrombopag Olamine PlaceboJiangsu Hengrui MedicinePhase 3
77
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 2
52

Other Products from Novartis

LCZ696Approved
85
zoledronic acidApproved
85
NateglinideApproved
85
TenofovirApproved
85
FTY720Approved
85